UCLA Drug Abuse Research CenterForever Free Evaluation Forever Free Substance Abuse Treatment Program Outcomes Study Michael Prendergast, Ph.D., Principal.

Slides:



Advertisements
Similar presentations
Amity In-Prison Therapeutic Community: Preliminary Five-Year Outcomes
Advertisements

Assessing Sexual Offenders Inmates for Residential Community-Based Addiction Treatment RC-BAT Peter R. Cohen MD, Medical Director, ADAA April 29, 2010.
XR-NTX Implementation in Los Angeles County Desirée A. Crèvecoeur-MacPhail, PhD UCLA Integrated Substance Abuse Programs Santa Monica Blvd., Suite.
Oklahoma Department of Corrections DUI Offender Profile
Gender Differences in Health Status Among Opiate Users in a 25-Year Follow-up Study Christine Grella & Luz Rodriguez UCLA Integrated Substance Abuse Programs.
Abstract People who enter substance abuse treatment under various degrees of legal pressure do at least as well at the end of treatment or at follow-up.
Predictors of Change in HIV Risk Factors for Adolescents Admitted to Substance Abuse Treatment Passetti, L. L., Garner, B. R., Funk, R., Godley, S. H.,
Background: The low retention rates among African Americans in substance abuse treatment (Milligan et al., 2004) combined with the limited number of treatments.
Differences in Characteristics of Heroin Inhalers and Injectors at Admission to Treatment J. C. Maxwell, R. T. Spence, & T. M. Bohman UT Center for Social.
The Catalyst Group, LLC Adolescent Residential Treatment Initiative I Mua Mau Ohana Project Preliminary Findings Richard Kim, Ph.D. 03/03/2005 Funded by.
Conducting Research in Challenging Times: California Parolee Reentry Court Evaluation Association of Criminal Justice Research, California March
Substance Use: Substance use comparisons included lifetime and past 30 day use (Figure 3) and lifetime use. For past 30 day use, more men reported heroin.
Preliminary Findings: Recovery Center Outcome Study
Foster Youth and the Transition to Adulthood: Findings from the Midwest Study Mark Courtney, Principal Investigator Amy Dworsky, Project Director.
Drug Offender Sentencing Alternative (DOSA): Treatment and Supervision
Paul L. Robinson, Norma Guzman-Becerra, Richard S. Baker Charles R. Drew University of Medicine and Science Didra Brown-Taylor, Integrated Substance Abuse.
1 The Importance of Successful Reentry to Jail Population Growth Presented by: Allen J. Beck, Chief Corrections Statistics Program Bureau of Justice Statistics.
Re-Entry and Recidivism
MARGUERITE BRYAN, PH.D. CRIMINAL JUSTICE INSTITUTE NOVA SOUTHEASTERN UNIVERSITY FORT LAUDERDALE, FLORIDA ACADEMY OF CRIMINAL JUSTICE SCIENCES ANNUAL CONFERENCE.
ENROLLING JUSTICE INVOLVED POPULATIONS: POLICY IMPLICATIONS LINDSAY NELSON KENTUCKY PRIMARY CARE ASSOCIATION.
Drug treatment in prisons: recent evidence Jessica Harris, RDS NOMS, Home Office Malcolm Ramsay, DSPD Programme, Home Office.
In the Community. Community Corrections Continues after incarceration And it deals with split sentences.
Evaluating Prison-Based Therapeutic Community Substance Abuse Programs: The California Initiative William M. Burdon, Ph.D. David Farabee, Ph.D. Michael.
Factors that Influence Retention in Greek Therapeutic Communities Erianna Daliani MSc (Gerasimos Papanastasatos) KETHEA Research Dept. 11th European Conference.
Audrey J. Brooks, PhD University of Arizona CA-AZ node.
The Source for Housing Solutions Returning Home Ohio Permanent Supportive Housing for Ex-Offenders October 10, 2013 OJACC Annual Conference.
Frequency and type of adverse events associated with treating women with trauma in community substance abuse treatment programs T. KIlleen 1, C. Brown.
NIDA Grants: U10DA015831, K24DA022288, U10DA020024, K23DA022297, U10DA Predictors of Outcome in the Multi-Site CTN Prescription Opioid Addiction.
This article and any supplementary material should be cited as follows: Harpaz-Rotem I, Rosenheck RA, Desai R. Residential treatment for homeless female.
The Rhode Island Experience Ellen Evans Alexander Assistant Director RI Department of Corrections.
LA County Cases: An Overview of Characteristics & Disposition Outcomes Denise C. Herz, Ph.D. California State University—Los Angeles School of Criminal.
PowerPoint Template ©2009 Texas Christian University, Center for Instructional Services. For Educational Use Only. Content is the property of the presenter.
Missouri Re-Entry Program Analysis of offender release factors from 2005 to 2011 and selected demographics Boone County Prepared for Boone.
Introduction The United States has one of the largest criminal justice populations in the world with over 6.94 million people under the supervision of.
METHODS Sample n=245 Women, 24% White, 72% Average age, 36.5 Never married, 51% Referral Sources (%) 12-Month DSM-IV Substance Dependence Prior to Entering.
EFFECTIVE INTERVENTIONS FOR NEWBORNS WITH DRUG EXPOSURE AND THEIR FAMILIES Harolyn M.E. Belcher, M.D., M.H.S. Associate Professor of Pediatrics Johns Hopkins.
Outcomes of Treatment for Methamphetamine Use: LA County (“Treatment-as-Usual”) M.-L. Brecht UCLA Integrated Substance Abuse Programs CATES 3/30/2004.
UCLA Integrated Substance Abuse Programs Gender-Responsive Drug Treatment Services for Women Offenders Elizabeth Hall, Ph.D. Criminal Justice Research.
Evaluations of CDCR Substance Abuse Programs: Lessons Learned Michael L. Prendergast, Ph.D. Criminal Justice Research Group UCLA Integrated Substance Abuse.
Gender Differences in Treatment Needs, Services, Utilization, and Outcomes Karol Kaltenbach, PhD Department of Pediatrics Jefferson Medical College Thomas.
Substance Abuse, Medication Adherence, and Criminality among Mentally Ill Parolees David Farabee & Sylvia Sanchez UCLA Integrated Substance Abuse Programs.
Are Incentives Effective in Improving Participation and Outcomes in Treatment for Substance-Abusing Offenders? Michael L. Prendergast, Ph.D. Elizabeth.
Risk and the Residential Environment: Prior Homelessness as a Predictor of HIV Risk among Adults Living in Single Room Occupancy Housing Elizabeth Bowen,
Gambling Among Latinos: A Secondary Analysis of the California Prevalence Survey OPG Problem Gambling Summit March 6, 2012 Michael Campos, PhD UCLA Gambling.
Method Introduction Results Discussion Psychological Disorder Diagnoses Across Ethnicities ??? ? ??? University of Nebraska-Lincoln Many people during.
Psychosocial Changes Among Special Populations in a Prison-based Therapeutic Community David Farabee, Michael Prendergast, & Jerome Cartier University.
UCLA Integrated Substance Abuse Programs Amity In-Prison Therapeutic Community: Five-Year Outcomes Association of Criminal Justice Research (CA) Sacramento,
Introduction Results and Conclusions Analyses of demographic and social variables revealed that women were more likely to have children, be living in a.
Midwest Evaluation of the Adult Functioning of Former Foster Youth: Outcomes at Age 19 Chapin Hall Center for Children University of Chicago.
Introduction Results Treatment Needs and Treatment Completion as Predictors of Return-to-Prison Following Community Treatment for Substance-Abusing Female.
UCLA CJ-DATS Pacific Coast Research Center Pacific Coast Research Center Michael L. Prendergast, Ph.D., Principal Investigator David Farabee, Ph.D., Co-Principal.
Substance Use among Older Adults (Age 50+): Current Prevalence and Future Expectations Presented by Joe Gfroerer U.S. DEPARTMENT OF HEALTH AND HUMAN SERVICES.
INTENSIVE SUPERVISION AND THE ROLE OF GPS Thomas H. Williams, Associate Director Community Supervision Services July 14-15, 2008 United States Sentencing.
Ready (or not) to graduate: Mental and physical health characteristics associated with completing public housing-based, substance abuse treatment in Key.
Methamphetamine Use Among Offenders Association for Criminal Justice Research (CA) March 17, 2005 Jerry Cartier / David Farabee / Michael Prendergast University.
Factors Associated with Third Trimester Prenatal Care among Women in Drug Treatment Benita Walton-Moss, DNS Jessica Conrad, MSN Johns Hopkins University.
Introduction Results and Conclusions Comparisons of psychiatric hospitalization rates in the 12 months prior to and after baseline assessment revealed.
Racial Disparities in Criminal Justice in Wisconsin Pamela Oliver.
UCLA Integrated Substance Abuse ProgramsForever Free Evaluation Residential Substance Abuse Treatment Programs for Women Laurie Bright, National Institute.
Association for Women in Psychology Conference “A Model of Integrated Treatment for Women with Co-Occurring Disorders who are at High Risk for HIV” Presented.
Introduction Results and Conclusions Numerous demographic variables were found to be associated with treatment completion. Completers were more likely.
BJS ReEntry Highlights (note: yearend 2002). BJS ReEntry At least 95% of all State prisoners will be released from prison at some point; nearly 80%
Results from the STEAM Survey Elizabeth Barash, MPH.
1 CLEAN COURT OUTCOME STUDY January, 2005 Charlene Rhyne, PhD.
Recidivism Rates for DCJ Offenders Exiting Residential Treatment June 2007 Kim Pascual Research & Evaluation.
Broadening the Study of Risk & Protective Factors for Depression, Drug Use, and HIV Risk among YMSM Healthy Young Men’s Study (HYM) Community, Health Outcomes,
Stress and Coping in a Mother-Child Residential Drug Treatment Program.
JAIL AND SHELTER USE IN THE RICHMOND REGION Margot Ackermann, Ph.D. (803) x11.
PURPOSE BACKGROUND RESULTS STUDY DESIGN & METHODS HIV Risk Behaviors Among Male Prisoners Participating in a Randomized Clinical Trial of Methadone Maintenance.
The relationship between incarceration and opioid addiction treatment
Presentation transcript:

UCLA Drug Abuse Research CenterForever Free Evaluation Forever Free Substance Abuse Treatment Program Outcomes Study Michael Prendergast, Ph.D., Principal Investigator Elizabeth A. Hall, Ph.D., Project Director Drug Abuse Research Center Integrated Substance Abuse Programs Neuropsychiatric Institute University of California, Los Angeles

UCLA Drug Abuse Research CenterForever Free Evaluation Background: What are the characteristics of national and state populations of women in prison and on parole?  Growing population increased by over 500% between 1980 and 1998  Mostly due to drug offenses 11% in 1979, by 1997 nearly 35%  Underclass population 70 to 90% were unemployed, 50% were functionally illiterate, 18% had psychiatric problems, and 10% were homeless

UCLA Drug Abuse Research CenterForever Free Evaluation Background: Forever Free Substance Abuse Treatment Program Started in 1991 Designed specifically for women Cognitive-behavioral model (Gorski) Participants housed separately, but mix with other inmates during meals and work assignments Intensive six-month program provided to volunteering women inmates during the end of their imprisonment Upon release, women may also volunteer for an additional six months of residential treatment in the community

UCLA Drug Abuse Research CenterForever Free Evaluation Aims Compare the 12-month outcomes of Forever Free participants with similar inmates from the general prison population on:  parole performance  drug use  employment  psychological functioning Determine what in-treatment variables predict outcome for Forever Free participants

UCLA Drug Abuse Research CenterForever Free Evaluation Subjects 215 inmates (119 enrolled in Forever Free; 96 in drug education) Housed at California Institution for Women near Chino Female Low educational attainment 66% have children under 18 Offenses were primarily drug or drug-related During the 30 days before incarceration, the treatment group reported spending an average of $125 on alcohol and $1,976 on illegal drugs

UCLA Drug Abuse Research CenterForever Free Evaluation Age and Ethnicity Treatment Comparison (N=119) (N=95) Age 1 Age in years (mean)3534 Ethnicity (percent) 2 White3631 African American3138 Latina2419 Other912 1 Independent sample t-test, differences were non-significant at p =.05 level. 2 Fishers Exact Test (2-Tail), differences were non-significant at p =.05 level.

UCLA Drug Abuse Research CenterForever Free Evaluation Drug Use History Treatment Comparison Primary Drug of Abuse (percent) 1 Cocaine/crack3654 Amphetamine/methamphetamine2816 Heroin and other opiates2521 Alcohol 6 6 Other drugs 4 3 Ever injected in lifetime (% yes)64*50 Received drug education or treatment during past incarcerations (% yes)25*39 1 Fishers Exact Test (2-Tail), differences were non-significant at p =.05 level. * Fishers Exact Test (2-Tail), p <.05.

UCLA Drug Abuse Research CenterForever Free Evaluation Arrest and Incarceration History Treatment Comparison Lifetime arrests (mean) Age first arrested (mean) Lifetime incarcerations (mean) Age first incarcerated (mean) 21N.A. Controlling case (percent) 2 Drug offenses6264 Robbery, burglary, forgery2726 Assault 44 Other 76 1 Independent sample t-test, differences were non-significant at p =.05 level. 2 Fisher’s Exact Test (2-tail), differences were non-significant at p =.05 level.

UCLA Drug Abuse Research CenterForever Free Evaluation Methods In-prison assessment:  Twice for the treatment group  Once for the comparison group (abbreviated form) One-year post-release interviews:  Telephone and face-to-face  Urine samples

UCLA Drug Abuse Research CenterForever Free Evaluation Methods: Status on 9/30/00

UCLA Drug Abuse Research CenterForever Free Evaluation Findings: Parole performance (percent) *** 1 *** p< p=.07

UCLA Drug Abuse Research CenterForever Free Evaluation Findings: Drug and alcohol use (percent) *** * *** p<.001 * p<.05

UCLA Drug Abuse Research CenterForever Free Evaluation Findings: Employment (percent) * 1 * p<.05 1 p=.08

UCLA Drug Abuse Research CenterForever Free Evaluation Findings: Psychological functioning (mean score) *** *** p<.001 ***

UCLA Drug Abuse Research CenterForever Free Evaluation Correlations

UCLA Drug Abuse Research CenterForever Free Evaluation Correlations

UCLA Drug Abuse Research CenterForever Free Evaluation Outcomes * Independent samples t-test, p <.05 1 p <.10

UCLA Drug Abuse Research CenterForever Free Evaluation Conclusions Women who received 6 months of prison-based treatment performed significantly better on parole on:  CJS variables  Drug use  Employment  Psychological functioning For the treatment group, some during-treatment psychological functioning and treatment motivation variables correlated with CJS and drug use outcomes